Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) EPS (Basic) (2019 - 2025)

Historic EPS (Basic) for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to -$1.16.

  • Biodesix's EPS (Basic) rose 1714.29% to -$1.16 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.96, marking a year-over-year increase of 33157.89%. This contributed to the annual value of -$0.33 for FY2024, which is 4847.98% up from last year.
  • According to the latest figures from Q3 2025, Biodesix's EPS (Basic) is -$1.16, which was up 1714.29% from -$0.08 recorded in Q2 2025.
  • Biodesix's 5-year EPS (Basic) high stood at -$0.06 for Q4 2024, and its period low was -$4.52 during Q2 2021.
  • Its 5-year average for EPS (Basic) is -$0.57, with a median of -$0.26 in 2021.
  • Per our database at Business Quant, Biodesix's EPS (Basic) skyrocketed by 9930.07% in 2021 and then tumbled by 90000.0% in 2024.
  • Biodesix's EPS (Basic) (Quarter) stood at -$0.49 in 2021, then soared by 32.65% to -$0.33 in 2022, then surged by 72.73% to -$0.09 in 2023, then increased by 28.01% to -$0.06 in 2024, then plummeted by 1690.47% to -$1.16 in 2025.
  • Its last three reported values are -$1.16 in Q3 2025, -$0.08 for Q2 2025, and -$0.08 during Q1 2025.